This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2001-2023.
Company Filing History:
1 out of 12,266 
Years Active: 2001-2023
Title: Hanns Ludwig: Innovator in Viral Detection and Vaccine Development
Introduction
Hanns Ludwig is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of virology, particularly in the detection of viral infections and the development of diagnostic kits. With a total of 2 patents, his work has implications for both human and animal health.
Latest Patents
Ludwig's latest patents include a method for detecting acute Borna disease virus (BDV) infections and a diagnostic kit designed for this purpose. This innovative method utilizes a sandwich ELISA to determine the presence of heterodimers of p24 BDV phosphoprotein and p40 BDV nucleoprotein in a sample. The diagnostic kit comprises antibodies for both proteins, a reporter-molecule-labelled secondary antibody, and instructions for use. This invention allows for the differentiation between acute, chronic, and latent BDV infections, facilitating better diagnosis and treatment monitoring.
Another significant patent involves equine herpesviruses (EHV) that contain foreign DNA elements. This invention outlines a process for preparing these viruses and their use in vaccines against EHV infections. The incorporation of foreign DNA enhances the potential for effective vaccine development.
Career Highlights
Throughout his career, Hanns Ludwig has worked with prominent companies, including Bayer Aktiengesellschaft. His experience in these organizations has contributed to his expertise in virology and vaccine development.
Collaborations
Ludwig has collaborated with notable individuals in his field, including Liv Bode and Gholamreza Darai. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Hanns Ludwig's contributions to viral detection and vaccine development underscore his importance as an inventor in the field of virology. His innovative methods and diagnostic kits have the potential to improve health outcomes for both humans and animals.